Black Rock Inc. Nuvation Bio Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NUVB
# of Institutions
163Shares Held
151MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$57.4 Million14.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$34.8 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$28.9 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$20.3 Million5.46% of portfolio
-
Laurion Capital Management LP New York, NY6.49MShares$14.3 Million0.33% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $480M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...